Home LiteratureArticle Details
PMID: 506797 Published · ppublish English Journal Article

Effect of physical training on different categories of patients with intermittent claudication.

Acta medica Scandinavica ·Vol. 206 ·No. 4 ·1979-00-00 ·Pages 253-8

Jonason T, Jonzon B, Ringqvist I, Oman-Rydberg A

Abstract

The effect of supervised training was studied in 68 patients with intermittent claudication. Maximal walking distance was measured on a treadmill. Eight of the patients had resting pain in the leg when recumbent (group A), 25 had an initial walking distance of less than 500 m (group B), 11 had an initial walking distance of 500--1 000 m (group C), 24 had coronary insufficiency (group D). The study shows that training should be undertaken for at least three months. In some patients with resting pain, training led to relief of pain and surgical treatment was not necessary. Almost all patients without signs of coronary insufficiency increased their walking distance, compared to only 14 of the 24 patients with coronary insufficiency. Walking distance increased significantly in groups B and C and no significant difference was found between patients and proximal or distal arterial stenosis.

MeSH Terms
Aged Angina Pectoris/rehabilitation Arterial Occlusive Diseases/rehabilitation Gait Hemodynamics Humans Intermittent Claudication/physiopathology,rehabilitation Middle Aged Pain Physical Exertion Time Factors
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Jonason T
Jonzon B
Ringqvist I
Oman-Rydberg A
Article Info
Journal
Acta medica Scandinavica
Abbr.
Acta Med Scand
ISSN
0001-6101
Published
1979-00-00
Pages
253-8
Language
English
Region
Sweden
NLM ID
0370330
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com